To the Editor There is now convincing evidence that ketamine has properties to provide prompt antidepressant effects, especially in patients with resistant mood and anxiety disorders.¹ Eventually, ketamine will be included in our daily practice. However, in addition to the concerns addressed by Sanacora et al,¹ there are a few further complications to be taken into consideration by any practitioner.

中文翻译：

---

氯胺酮治疗抑郁症

致编辑现在有令人信服的证据表明，氯胺酮具有提供即时抗抑郁作用的特性，尤其是在患有耐药性情绪和焦虑症的患者中。¹最终，氯胺酮将被纳入我们的日常实践中。然而，除了 Sanacora 等人¹解决的问题外，任何从业者都需要考虑一些进一步的并发症。